Rural hospitals are facing growing cybersecurity threats and digital demands but often lack the resources to respond — a gap ...

Digital health funding held steady in the first half of 2025, with AI-focused startups capturing the majority of capital and driving rapid adoption among providers. The digital health space also saw ...

June has seen a slew of executive hires, promotions, exits and layoffs across the healthcare sector. For example, CVS Health ...

The Trump administration's healthcare policy changes from the gutting of medical research grants to changes on the CDC vaccine board were the focus of the discussion on the latest episode of the ...

Well-designed technology can empower people to gather healthcare data at home that was previously available only in hospitals or some medical centers. A growing array of RPM devices can conduct ...

By reimagining the payment experience through transparency, flexibility, and technology, providers can drive better outcomes for both their bottom line and the patients they serve.

Insmed reported that the low dose of brensocatib led to a 21.1% reduction in the rate of pulmonary exacerbations compared to placebo measured at 52 weeks; the high dose achieved a 19.4% reduction ...

Precision medicine is a relatively new approach to preempting, diagnosing, and treating disease. Thanks to human genome sequencing, healthcare data analytics, and an increased understanding of how ...

The Supreme Court upheld the constitutionality of an Affordable Care Act provision requiring insurance coverage of certain preventive services without cost-sharing. Many healthcare leaders applauded ...

Study researchers interviewed 12 primary care physicians in leadership positions and other primary care experts. They also held focus groups with 17 frontline primary care providers who haven’t ...

This week, health data platform Arcadia acquired CareJourney, a health analytics firm designed to facilitate participation in value-based care contracts. The deal combines Arcadia’s data ...

Novavax’s alliance with Sanofi came at an opportune time for the beleaguered vaccine developer. Its protein-based Covid-19 vaccine never reached the revenue highs achieved by the messenger RNA ...